Drew Moghanaki, Chief Medical Officer at Respirati and Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology at David Geffen School of Medicine at UCLA, shared a post on X:
“Excited to be a part of this collaboration with friends and colleagues in Amsterdam.
It isn’t inspired entirely to advance SABR in place of surgery; instead, it is about identifying how often adrenalectomies end up with positive margins and local recurrence. The preliminary data shows it happens >50% of the time.”
More posts featuring Drew Moghanaki on OncoDaily.